PT  - JOURNAL ARTICLE
AU  - Pokhraj P. Suthar
AU  - Jagadeesh S. Singh
AU  - Khushboo Gupta
TI  - <sup>18</sup>F-FDG PET/CT Imaging Features of Cardiac Arrhythmia in a Patient Treated with Panitumumab
AID  - 10.2967/jnmt.121.262216
DP  - 2021 Dec 01
TA  - Journal of Nuclear Medicine Technology
PG  - 360--361
VI  - 49
IP  - 4
4099  - http://tech.snmjournals.org/content/49/4/360.short
4100  - http://tech.snmjournals.org/content/49/4/360.full
SO  - J. Nucl. Med. Technol.2021 Dec 01; 49
AB  - Panitumumab is a new humanized antiepidermal growth factor receptor monoclonal antibody (mAb) approved for the treatment of advanced colorectal cancer. There is an increase in the use of this drug due to a good response rate and possible secondary resection in advanced colorectal cancer. Here, we present 18F-FDG PET/CT imaging findings of cardiac arrhythmia in a patient receiving panitumumab for the treatment of metastatic infiltrating rectal adenocarcinoma. Cardiotoxicity is a known adverse effect associated with panitumumab. So far, to our knowledge, no documented imaging findings for the same are available in the literature.